ASTRO: Patient Experience of Radiation Better Than Expected

Share this content:
ASTRO: Patient Experience of Radiation Better Than Expected
ASTRO: Patient Experience of Radiation Better Than Expected

THURSDAY, Sept. 28, 2017 (HealthDay News) -- Most patients with breast cancer treated with radiation therapy (RT) report that their experience was less scary than they expected, according to a study presented at the annual meeting of the American Society for Radiation Oncology (ASTRO), held from Sept. 24 to 27 in San Diego.

Narek Shaverdian, M.D., from the University of California, Los Angeles, and colleagues surveyed 327 patients with breast cancer treated from 2012 to 2016 about their pre-treatment RT beliefs compared with their actual experience.

The researchers found that at the time of diagnosis, the most feared treatment was chemotherapy, surgery, RT, and endocrine therapy for 55, 36, 7, and 5 percent of patients, respectively. Sixty-eight percent of patients reported having little to no knowledge about RT initially; 47 percent reported that they had heard or read frightening stories. Damage to internal organs, skin burning, and being radioactive were the most commonly ranked fears about RT (40, 24, and 7 percent, respectively). Overall, 83 and 84 percent reported short-term and long-term side effects to be better than or as expected, respectively. Only 2 and 3 percent of women agreed that the negative stories they had initially heard and read were actually true; 90 percent agreed that their experience was less scary than expected.

"The negative stories out there are frightening and pervasive, but they generally are not reflective of the actual experience," one of the co-authors said in a statement.

News Release/Abstract
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Lyme-Bearing Ticks More Widespread in U.S. Than Thought

Lyme-Bearing Ticks More Widespread in U.S. Than Thought

Disease-carrying ticks were detected in 83 counties where they'd never been found before

Availability of Generic Antivirals for Hepatitis B Increasing

Availability of Generic Antivirals for Hepatitis B Increasing

Drop in median price of WHO-prequalified generic tenofovir from $208 to $32 from 2004 to 2016

Visual Function Deficits Up in Developmental Dyslexia

Visual Function Deficits Up in Developmental Dyslexia

Increased prevalence of deficits in visual function versus typically developing school-age children

is free, fast, and customized just for you!




Already a member?

Sign In Now »